Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catrin O Plumpton

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Pharmacogenomics|January 13, 2018
Rare disease prevention and treatment: the need for a level playing fieldDyfrig A Hughes, Catrin O Plumpton
Clinical Pharmacology and Therapeutics|November 23, 2018
Cost-Effectiveness of Panel Tests for Multiple Pharmacogenes Associated With Adverse Drug Reactions: An Evaluation FrameworkCatrin O Plumpton, Munir Pirmohamed, Dyfrig A Hughes
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 14, 2018
Societal Preferences for Funding Orphan Drugs in the United Kingdom: An Application of Person Trade-Off and Discrete Choice Experiment MethodsSiobhan M Bourke, Catrin O Plumpton, Dyfrig A Hughes
Pharmacoeconomics|March 18, 2016
A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug ReactionsCatrin O Plumpton, Daniel Roberts, Munir Pirmohamed, et al.
Rheumatology (Oxford, England)|September 29, 2017
Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for goutCatrin O Plumpton, Ana Alfirevic, Munir Pirmohamed, et al.
BMC Research Notes|January 27, 2016
Multiple imputation of multiple multi-item scales when a full imputation model is infeasibleCatrin O Plumpton, Tim Morris, Dyfrig A Hughes, et al.
Frontiers in Pharmacology|October 5, 2017
Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical TrialColin H Ridyard, Catrin O Plumpton, Ruth E Gilbert, et al.
British Journal of Clinical Pharmacology|December 9, 2025
Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in PharmacogenomicsDyfrig A Hughes, Henry Fong, Grace Hampson, et al.
Epilepsy & Behavior : E&B|March 31, 2015
Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherenceCatrin O Plumpton, Ian Brown, Markus Reuber, et al.
IEEE Transactions on Medical Imaging|February 5, 2010
Random subspace ensembles for FMRI classificationLudmila I Kuncheva, Juan J Rodriguez, Catrin O Plumpton, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Pharmacogenomics|January 13, 2018
Rare disease prevention and treatment: the need for a level playing fieldDyfrig A Hughes, Catrin O Plumpton
Clinical Pharmacology and Therapeutics|November 23, 2018
Cost-Effectiveness of Panel Tests for Multiple Pharmacogenes Associated With Adverse Drug Reactions: An Evaluation FrameworkCatrin O Plumpton, Munir Pirmohamed, Dyfrig A Hughes
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 14, 2018
Societal Preferences for Funding Orphan Drugs in the United Kingdom: An Application of Person Trade-Off and Discrete Choice Experiment MethodsSiobhan M Bourke, Catrin O Plumpton, Dyfrig A Hughes
Pharmacoeconomics|March 18, 2016
A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug ReactionsCatrin O Plumpton, Daniel Roberts, Munir Pirmohamed, et al.
Rheumatology (Oxford, England)|September 29, 2017
Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for goutCatrin O Plumpton, Ana Alfirevic, Munir Pirmohamed, et al.
BMC Research Notes|January 27, 2016
Multiple imputation of multiple multi-item scales when a full imputation model is infeasibleCatrin O Plumpton, Tim Morris, Dyfrig A Hughes, et al.
Frontiers in Pharmacology|October 5, 2017
Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical TrialColin H Ridyard, Catrin O Plumpton, Ruth E Gilbert, et al.
British Journal of Clinical Pharmacology|December 9, 2025
Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in PharmacogenomicsDyfrig A Hughes, Henry Fong, Grace Hampson, et al.
Epilepsy & Behavior : E&B|March 31, 2015
Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherenceCatrin O Plumpton, Ian Brown, Markus Reuber, et al.
IEEE Transactions on Medical Imaging|February 5, 2010
Random subspace ensembles for FMRI classificationLudmila I Kuncheva, Juan J Rodriguez, Catrin O Plumpton, et al.
Pageof 2